BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11132966)

  • 1. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells.
    Kim YB; Ki SW; Yoshida M; Horinouchi S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1191-200. PubMed ID: 11132966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
    Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
    Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
    Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.
    Chen JS; Faller DV
    J Cell Physiol; 2005 Jan; 202(1):87-99. PubMed ID: 15389542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
    Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
    Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
    Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
    Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
    Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
    Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
    Ding QM; Ko TC; Evers BM
    Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.